SEC Filing Analysis: Camp4 Therapeutics Corp

Executive Summary

• Trading Significance: Low
• Key Takeaway: This Schedule 13G/A is a minor administrative filing by institutional investor Coastlands Capital LP to correct a typographical rounding error in its previously reported 9.99% stake in Camp4 Therapeutics Corp.
• Market Impact: Neutral. The filing provides no new material information and simply reaffirms an existing, publicly known ownership position.

Company Information

Field	Value
Company	Camp4 Therapeutics Corp
Ticker Symbol	Not Available
CIK	0001736730
Industry	Pharmaceutical Preparations

Investor Information

Field	Value
Name	Coastlands Capital LP
CIK	0002068530
Title/Position	Investment Adviser
Relationship	10% Owner

Position Details

Field	Value
Form Type	SCHEDULE 13G/A
Event Date	2025-09-10
Security Type	Common stock, par value $0.0001 per share
Shares Beneficially Owned	4,886,722
Percent of Class	9.99%
Ownership Type	Indirect

Financial Impact Assessment

This filing does not report a new transaction. The analysis below pertains to the materiality of the holding itself, not the amendment.

Holding Materiality

Metric	Value
Shares Held	4,886,722
% of Shares Outstanding	9.99%
Implied Holding Value	~$19.8 million (based on $190M market cap and 9.99% stake)
% of Market Cap	~9.99%
Materiality Assessment	The underlying holding is Highly Significant, representing a substantial passive investment. However, the significance of this amendment filing is Low.

Impact Evaluation

• Market Cap Context: For Camp4 Therapeutics, a small-cap company with a $190 million market capitalization, a single investor holding a stake valued at nearly $20 million is a major factor in its ownership structure.
• Ownership Concentration: Coastlands Capital's 9.99% stake makes it one of the largest shareholders. The position is intentionally kept just below the 10% threshold, which carries additional reporting requirements.
• Transaction Significance: The filing itself is non-substantive. It merely corrects a rounding error from a previous disclosure related to a private placement that closed on September 11, 2025.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The filing is purely administrative and does not alter the market's understanding of Coastlands Capital's position. No price movement is expected as a result of this filing.

Volume & Sentiment

• Expected Volume Impact: None. This is not a trade and provides no new information to act upon.
• Sentiment Indicator: Neutral. The filing confirms the status quo.

Additional Context

Filing Notes

• Purpose: The filing explicitly states its sole purpose is to correct a "typographical rounding error correction in Item 11 of the cover sheet" from the original Schedule 13G filed on September 16, 2025.
• Share Count Basis: The 9.99% calculation is based on 46,842,126 total shares outstanding, comprising 20,161,073 shares as of the last 10-Q and an additional 26,681,053 shares issued in a September 2025 private placement.